Position in LQDA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,609,643
+$4,245,968 QoQ
Shares Held
145,612
-25.4% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 334 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. LQDA ranks #17 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in LQDA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,609,643 | 145,612 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $7,363,675 | 195,116 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $4,196,087 | 121,661 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $634,945 | 27,922 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $399,093 | 32,030 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $922,212 | 62,523 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $331,689 | 28,205 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,353,930 | 235,393 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $295,680 | 24,640 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $288,967 | 19,591 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $377,765 | 31,402 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $204,230 | 32,213 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $288,903 | 36,803 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $258,115 | 37,354 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $177,868 | 27,923 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $141,864 | 26,078 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $111,245 | 25,515 | Shares | Defined | 2022-08-11 | |
| 2021-06-30 | $227,375 | 79,502 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $93,547 | 34,776 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $35,385 | 11,995 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $49,687 | 10,099 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $199,241 | 23,663 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $37,104 | 7,878 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||